| HOME >> BIOLOGY >> TECHNOLOGY |
Restricted cash for
investing activity (200,000) -- --
Sale of investment -- 37,175 --
Acquisition of property
and equipment (6,809,173) (412,717) (19,659)
Construction in progress -- (515,742) --
Net cash provided by
(used in) investing
activities (7,009,173) (891,284) (19,659)
CASH FLOWS FROM FINANCING
ACTIVITIES:
Repayment from / (Advance
to) shareholder 22,617 (738) (12,790)
Repayment of short term
loan (1,577,744) -- --
Proceeds from short term
loan 269,531 1,019,231 --
Repayment of long term
notes payable (4,235) -- (21,800)
Proceeds from long term
notes payable -- 89,697 --
Issuance of preferred
stock 9,774,993 -- --
Capital contribution 3,905,724 -- --
Notes payable - trade -- (743,494) 743,494
Notes payable -
related party -- 290,726 (713,912)
Restricted cash 657,811 225,977 (14,791)
Net cash provided by
(used in) financing
activities 13,048,697 881,399 (19,799)
NET INCREASE (DECREASE) IN
CASH AND CASH EQUIVALENTS 931,221 10,663 (260,902)
EFFECT OF EXCHANGE RATE CHANGE
ON CASH AND CASH EQUIVALENTS (180,293) 464,099 128,033
CASH AND CASH EQUIVALENTS,
B
'/>"/>
| SOURCE China Bio Energy Holding Group Co., Ltd. Copyright©2008 PR Newswire. All rights reserved |